Background: Interleukin (IL)-4 and IL-13, which play a role in the production of allergic inflammation, can activate fibroblasts to elicit a variety of cellular functions. However, the effect of IL-4 and IL-13 on fibronectin production by human lung fibroblasts (HLF) has not been determined. In the present study, we examined the effect of IL-4 and IL-13 on fibronectin production by HLF in order to clarify these issues. Methods: We stimulated HLF with various concentrations of IL-4 and IL-13 for 12, 24, 48 and 72 h and fibronectin concentrations in the culture supernatants were determined by ELISA.
INTRODUCTION
Airway remodeling has been documented to be a prominent feature of the bronchial wall of patients with chronic severe asthma. [1] [2] [3] Many elements contribute to the airway remodeling response, which involves basement membrane thickening associated with subepithelial extracellular matrix deposition and subepithelial fibrosis. [1] [2] [3] Bronchial asthma is a disease that is characterized by episodic reversible airway obstruction, airway hyperresponsiveness and allergic inflammation in the airway. 4 T helper (h) 2 cytokines play a key role in the production of allergic inflammation of asthma. 5 Of the Th2 cytokines, it has been demonstrated that the interleukin (IL)-4 and IL-13 receptors are expressed in fibroblasts 6, 7 and that IL-4 and IL-13 elicit various fibroblast cell functions, including cytokine and adhesion molecule expression and extracellular matrix protein synthesis. [8] [9] [10] [11] [12] These observations indicate that IL-4 and IL-13 play a role in the airway remodeling response of asthma. Interleukin-4 has been shown to induce fibronectin production by human synovial fibroblasts from patients with rheumatoid arthritis and osteoarthritis and infant dermal fibroblasts. 8 However, little is known about the effect of IL-4 on fibronectin production by lung fibroblasts derived from healthy subjects. Furthermore, the role of IL-13 in fibronectin production has not been determined. Therefore, in the present study clarified the role of IL-4 and IL-13 in fibronectin production by examining the role of IL-4 and IL-13 in fibronectin production by normal human lung fibroblasts (HLF). To this end, we attempted to examine the effect of IL-13 as well as IL-4 on fibronectin production by HLF.
METHODS

Cells and reagents
Human lung fibroblasts were obtained from Clonetics (San Diego, CA, USA). Human lung fibroblasts were grown in a culture medium that was fibroblast growth medium (FGM-2; Clonetics) containing 0.2% fetal bovine serum (FBS), gentamycin-amphotericin B, fibroblast growth factor (FGF) and insulin. 
Cell cultures
For the determination of fibronectin production, cells were placed onto collagen-coated 24-well flat-bottomed tissue culture plates (Iwaki, Tokyo, Japan) and cultured using culture medium at 37°C in a humidified 5% CO 2 atmosphere. When cells had grown to subconfluency, the culture medium was replaced with FGM-2 medium without FBS, FGF and insulin (growth factor-free medium) for 16 h. In order to determine fibronectin production by IL-4-and IL-13-stiumlated HLF, cells were stimulated with various concentrations of IL-4 and IL-13 and cultured for various lengths of time, as indicated. The examine the effects of anti-TGF-β 1 ab on IL-4-and IL-13-induced fibronectin production, cells that had been incubated with anti-TGF-β 1 ab for 1 h were stimulated with IL-4 or L-13 and cultured.
Measurement of fibronectin and TGF-β 1
The concentrations of fibronectin in the culture supernatants from HLF were measured by commercially available ELISA kits (Chemicon International, Temecula, CA, USA). The concentrations of TGF-β 1 in culture supernatants from HLF were measured by commercially available ELISA kits (Genzyme Techne). The minimum detectable concentration of TGF-β 1 was 7 pg/mL. The ELISA was performed according to the manufacturer's instructions. All samples were assayed in duplicate.
Statistical analysis
Statistical significance was analyzed using analysis of variance (ANOVA). P < 0.05 was considered significant.
RESULTS
Interleukin-4 and IL-13 induce fibronectin production in a time-dependent manner First, we examined the time-dependent effects of IL-4 and IL-13 on fibronectin production by HLF. To this end, the culture supernatants from HLF stimulated with 100 ng/mL IL-4 or 100 ng/mL IL-13 were harvested at 12, 24, 48 and 72 h after cultivation. The concentration of fibronectin in the culture supernatants from IL-4-stimulated HLF increased at 12 h, was maximal at 48 h and decreased at 72 h ( Fig. 1) . Similarly, the concentration of fibronectin in culture supernatants from IL-13-stimulated HLF increased in a time-dependent manner ( Fig. 1) . In order to establish the specificity of the regulatory effect of IL-4 and IL-13 on fibronectin production, HLF that had been incubated with anti-IL-4 ab or anti-IL-13 ab were stimulated with IL-4 or IL-13 and the concentration of fibronectin in the culture supernatants was then determined at 48 h. At 50 µg/mL anti-IL-4 ab, a concentration that was sufficient for neutralizing IL-4 activity (500 ng/mL), fibronectin production by IL-4-stimulated HLF was abolished. Similarly, 50 µg/mL anti-IL-13 ab, which was sufficient for neutralizing IL-13 activity (500 ng/mL), abolished fibronectin production by IL-13-stimulated HLF. Isotype-matched control mouse IgG had no effect on fibronectin production by IL-4-and IL-13-stimulated HLF (data not shown). These results establish the specificity of the regulatory effect of these cytokines on fibronectin production.
IL-4 and IL-13 induce fibronectin production in a concentration-dependent manner
In the next series of experiments, we examined the concentration-dependent effects of IL-4 and IL-13 on fibronectin production by HLF. To this end, culture supernatants from HLF stimulated with various concentrations of IL-4 or IL-13 were harvested at 48 h after cultivation. The concentration of fibronectin in culture supernatants from IL-4-stimulated HLF increased in a concentrationdependent manner when HLF were stimulated with 0.1-100 ng/mL IL-4 (Fig. 2) . When HLF were stimulated with 500 ng/mL IL-4, fibronectin production was not enhanced further. Similar observations were obtained for IL-13-stimulated HLF (Fig. 2) . Interleukin-5 did not induce fibronectin production by HLF (data not shown).
Transforming growth factor-β 1 induces fibronectin production and a combination of TGF-β 1 and IL-4 or IL-13 additively induces fibronectin production
The concentration of fibronectin in culture supernatants from TGF-β 1 -stimulated HLF at 48 h after cultivation increased in a concentration-dependent manner (Fig. 3) . When cells were stimulated with a combination of TGF-β 1 (10 ng/mL) and IL-4 (100 ng/mL), TGF-β 1 and IL-4 additively induced fibronectin production (Fig. 4) . Similar observations were obtained for HLF cultures stimulated with TGF-β 1 (10 ng/mL) and IL-13 (100 ng/mL; Fig. 4 ). In contrast, when cells were stimulated with a combination of IL-4 (100 ng/mL) and IL-13 (100 ng/mL), the concentration of fibronectin in culture supernatants from HLF stimulated with IL-4 and IL-13 was comparable to that from HLF stimulated with IL-4 or IL-13 alone (Fig. 4) . Human lung fibroblasts were stimulated with TGF-β 1 (10 ng/mL) in the presence of anti-TGF-β 1 ab and it was observed that anti-TGF-β 1 ab abolished the effects of TGF-β 1 on fibronectin production. When HLF were stimulated with IL-4 (100 ng/mL) or IL-13 (100 ng/mL) in the presence of anti-TGF-β 1 ab, anti-TGF-β 1 ab did not affect IL-4-and IL-13-induced fibronectin production (Fig. 5) . In addition, the concentration of TGF-β 1 in IL-4-and IL-13-stimulated cultures was below the sensitivity limits of the assay (data not shown). The concentration of anti-TGF-β 1 ab used in the present study (100 µg/mL) was sufficient to neutralize TGF-β 1 activity (100 ng/mL). Isotype-matched control mouse IgG had no effect on fibronectin production by TGF-β 1 -, IL-4-and IL-13-stimulated HLF (data not shown).
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DISCUSSION
In the present study, we attempted to clarify the role of IL-4 and IL-13 in airway remodeling by examining the effect of IL-4 and IL-13 on fibronectin production by HLF. We focused on the effect of these cytokines on fibronectin production by HLF because an increased deposition of fibronectin has been shown at the site of airway remodeling. 1, 13 The results of the present study showed that IL-4 induced fibronectin production in a time-and
200
T MACHINO ET AL. Fig. 4 A combination of transforming growth factor (TGF)-β 1 and interleukin (IL)-4 or IL-13 additively induces fibronectin production. Human lung fibroblasts (HLF) were stimulated with TGF-β 1 (10 ng/mL) and either IL-4 (100 ng/mL) or IL-13 (100 ng/mL) and cultured for 48 h. The concentration of fibronectin in culture supernatants was determined by ELISA. The results are expressed as the mean ± SD of five experiments. *P < 0.01 compared with fibronectin concentrations in culture supernatants from HLF cultured with IL-4 or IL-13 alone and P < 0.05 compared with fibronectin concentrations in culture supernatants from HLF cultured with TGF-β 1 only.
Fig. 5
Anti-transforming growth factor (TGF)-β 1 antibody (ab) inhibits TGF-β 1 -but not IL-4-and IL-13-induced fibronectin production. Human lung fibroblasts (HLF) that had been incubated with a sufficient concentrations of anti-TGF-β 1 ab for neutralizing TGF-β 1 were stimulated with TGF-β 1 (10 ng/mL), IL-4 (100 ng/mL) or IL-13 (100 ng/mL) and cultured for 48 h. The concentration of fibronectin in culture supernatants was determined by ELISA. The results are expressed as the mean ± SD of five experiments. *P < 0.01 compared with fibronectin concentrations in culture supernatants from HLF cultured with TGF-β 1 .
concentration-dependent manner. Similar observations were obtained for IL-13-stimulated HLF. Interleukin-13 shares many functional activities with IL-4 and uses similar receptor subunits for signaling. 6, 14 Interleukin-4 has been shown to induce fibronectin production by fibroblastic cell lines. 8 The results of the present study showed that IL-4 was capable of inducing fibronectin production by HLF as well as fibroblastic cell lines and that IL-13 had a similar activity to IL-4 in inducing fibronectin production by HLF. In addition, when HLF were stimulated with a combination of IL-4 and IL-13, an additive effect was not seen. These results indicate that IL-4 and IL-13 use a common pathway to induce fibronectin production by HLF.
Because TGF-β 1 is known to induce fibronectin production by fibroblasts, 15, 16 TGF-β 1 may be responsible for the induction of fibronectin production by IL-4-and IL-13-stimulated HLF. To test this possibility, we examined the effect of anti-TGF-β 1 ab on fibronectin production by IL-4-and IL-13-stimulated cultures and measured TGF-β 1 concentrations in IL-4-and IL-13-stimulated cultures. The results were as follows: (i) anti-TGF-β 1 ab did not affect IL-4-and IL-13-induced fibronectin production; and (ii) the concentration of TGF-β 1 in IL-4-and IL-13-stimulated cultures was below the sensitivity limits of the assay. These results indicate that IL-4 and IL-13 are capable of inducing fibronectin production by HLF and that TGF-β 1 is not involved in the IL-4-and IL-13-induced production of fibronectin by HLF.
It is generally accepted that the airway remodeling response is preceded by allergic inflammation and that Th2 cytokines, such as IL-4 and IL-13, play a key role in the production of allergic inflammation. 5, 13 Several lines of study have suggested that IL-4 and IL-13 play a role in the development of airway remodeling. Interleukin-4 and IL-13 can activate fibroblasts to elicit a variety of cellular functions, including extracellular matrix production. [8] [9] [10] [11] [12] Pulmonary overexpression of IL-13 causes allergic inflammation and subepithelial fibrosis 17 and IL-13 inhibitors block the development of fibrogenic process. 18 In addition to this evidence, the present results with IL-4-and IL-13-induced production of fibronectin by HLF indicate that IL-4 and IL-13 may play a role in the development of fibrogenic processes in airway remodeling by inducing fibronectin production by HLF. We simultaneously examined the effect of another Th2 cytokine, namely IL-5, on fibronectin production by HLF. Interleukin-5 did not induce fibronectin production, indicating that IL-4 and IL-13, but not all Th2 cytokines, can induce fibronectin production by HLF.
The pathogenesis of airway remodeling is complex. Multiple inflammatory cells, cytokines and mediators participate in the pathogenesis of airway remodeling. Fibroblasts are involved in the development of fibrogenic process in airway remodeling by producing extracellular matrix. Therefore, an understanding of the mechanism of fibronectin production would suggest a strategy for therapy to control the development of fibrogenic processes in airway remodeling in bronchial asthma.
From the data presented here, we conclude that the Th2 cytokines IL-4 and IL-13 play an important role in the production of airway remodeling by inducing fibronectin production by HLF, as well as allergic inflammation.
